Reported 3 months ago
Humana announced an unexpected rise in medical care demand during the second quarter of the year, leading to an 8.6% drop in its stock price. The increase in inpatient admissions and higher costs in the Medicare Advantage market have raised concerns about the industry's future, despite the company's ability to exceed profit estimates. Analysts view Humana's cautious forecast as a sign of ongoing instability in medical costs.
Source: YAHOO